TY - JOUR
T1 - Current management of hemorrhage from severe pelvic fractures
T2 - Results of an American Association for the Surgery of Trauma multi-institutional trial
AU - the AAST Pelvic Fracture Study Group
AU - Costantini, Todd W.
AU - Coimbra, Raul
AU - Holcomb, John B.
AU - Podbielski, Jeanette M.
AU - Catalano, Richard
AU - Blackburn, Allie
AU - Scalea, Thomas M.
AU - Stein, Deborah M.
AU - Williams, Lashonda
AU - Conflitti, Joseph
AU - Keeney, Scott
AU - Suleiman, Ghada
AU - Zhou, Tianhua
AU - Sperry, Jason
AU - Skiada, Dimitra
AU - Inaba, Kenji
AU - Williams, Brian H.
AU - Minei, Joseph P.
AU - Privette, Alicia
AU - MacKersie, Robert C.
AU - Robinson, Brenton R.
AU - Moore, Forrest O.
N1 - Publisher Copyright:
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016/3/8
Y1 - 2016/3/8
N2 - BACKGROUND: There is no consensus as to the optimal treatment paradigm for patients presenting with hemorrhage from severe pelvic fracture. This study was established to determine the methods of hemorrhage control currently being used in clinical practice. METHODS: This prospective, observational multi-center study enrolled patients with pelvic fracture from blunt trauma. Demographic data, admission vital signs, presence of shock on admission (systolic blood pressure < 90 mm Hg or heart rate > 120 beats per minute or base deficit < -5), method of hemorrhage control, transfusion requirements, and outcome were collected. RESULTS: A total of 1,339 patientswith pelvic fracturewere enrolled from11 Level I trauma centers. Fifty-seven percent of the patientsweremale, with a mean ± SD age of 47.1 ± 21.6 years, and Injury Severity Score (ISS) of 19.2 ± 12.7. In-hospital mortality was 9.0 %. Angioembolization and external fixator placement were the most common method of hemorrhage control used. A total of 128 patients (9.6%) underwent diagnostic angiography with contrast extravasation noted in 63 patients. Therapeutic angioembolization was performed on 79 patients (5.9%). There were 178 patients (13.3%) with pelvic fracture admitted in shock with a mean ± SD ISS of 28.2 ± 14.1. In the shock group, 44 patients (24.7%) underwent angiography to diagnose a pelvic source of bleeding with contrast extravasation found in 27 patients. Thirty patients (16.9%) were treated with therapeutic angioembolization. Resuscitative endovascular balloon occlusion of the aorta was performed on five patients in shock and used by only one of the participating centers. Mortality was 32.0% for patients with pelvic fracture admitted in shock. CONCLUSION: Patients with pelvic fracture admitted in shock have high mortality. Several methods were used for hemorrhage control with significant variation across institutions. The use of resuscitative endovascular balloon occlusion of the aorta may prove to be an important adjunct in the treatment of patients with severe pelvic fracture in shock; however, it is in the early stages of evaluation and not currently used widely across trauma centers.
AB - BACKGROUND: There is no consensus as to the optimal treatment paradigm for patients presenting with hemorrhage from severe pelvic fracture. This study was established to determine the methods of hemorrhage control currently being used in clinical practice. METHODS: This prospective, observational multi-center study enrolled patients with pelvic fracture from blunt trauma. Demographic data, admission vital signs, presence of shock on admission (systolic blood pressure < 90 mm Hg or heart rate > 120 beats per minute or base deficit < -5), method of hemorrhage control, transfusion requirements, and outcome were collected. RESULTS: A total of 1,339 patientswith pelvic fracturewere enrolled from11 Level I trauma centers. Fifty-seven percent of the patientsweremale, with a mean ± SD age of 47.1 ± 21.6 years, and Injury Severity Score (ISS) of 19.2 ± 12.7. In-hospital mortality was 9.0 %. Angioembolization and external fixator placement were the most common method of hemorrhage control used. A total of 128 patients (9.6%) underwent diagnostic angiography with contrast extravasation noted in 63 patients. Therapeutic angioembolization was performed on 79 patients (5.9%). There were 178 patients (13.3%) with pelvic fracture admitted in shock with a mean ± SD ISS of 28.2 ± 14.1. In the shock group, 44 patients (24.7%) underwent angiography to diagnose a pelvic source of bleeding with contrast extravasation found in 27 patients. Thirty patients (16.9%) were treated with therapeutic angioembolization. Resuscitative endovascular balloon occlusion of the aorta was performed on five patients in shock and used by only one of the participating centers. Mortality was 32.0% for patients with pelvic fracture admitted in shock. CONCLUSION: Patients with pelvic fracture admitted in shock have high mortality. Several methods were used for hemorrhage control with significant variation across institutions. The use of resuscitative endovascular balloon occlusion of the aorta may prove to be an important adjunct in the treatment of patients with severe pelvic fracture in shock; however, it is in the early stages of evaluation and not currently used widely across trauma centers.
KW - Angioembolization
KW - Hemorrhage control
KW - Pelvis
KW - REBOA
UR - http://www.scopus.com/inward/record.url?scp=84989803096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84989803096&partnerID=8YFLogxK
U2 - 10.1097/TA.0000000000001034
DO - 10.1097/TA.0000000000001034
M3 - Article
C2 - 26958799
AN - SCOPUS:84989803096
SN - 2163-0755
VL - 80
SP - 717
EP - 725
JO - Journal of Trauma and Acute Care Surgery
JF - Journal of Trauma and Acute Care Surgery
IS - 5
ER -